Live attenuated vaccines.

<p>Live attenuated vaccines.</p

Approaches to LAV generation.

<p>Approaches to LAV generation.</p

Distribution of muscle biopsies taken from 10 LGMD2A patients and 10 control subjects.

<p>Distribution of muscle biopsies taken from 10 LGMD2A patients and 10 control subjects.</p

Significantly differentially regulated transcripts comparing patients with eosinophilic infiltrates to healthy controls.

<p>Significantly differentially regulated transcripts comparing patients with eosinophilic infiltrates to healthy controls.</p

Principal component analysis (PCA) of HG-U133A microarrays (A) and of HG-U133B microarrays (B) after normalization.

<p>P: LGMD2A Patients. C: Healthy controls. Muscle specimens obtained from individuals of the same status showed the greatest similarities.</p